Biometric magnetic resonance imaging analysis of fetal brain development in Down syndrome
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Rie Kitano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan. Hauptthemen laut MEDLINE: Down Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Intramural NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Objectives
To assess brain development in living fetuses with Down syndrome (DS) by biometric measurements on fetal brain magnetic resonance images (MRI).
Methods
We scanned 10 MRIs of fetuses with confirmed trisomy 21 at birth and 12 control fetal MRIs without any detected anomalies. Fetal brain MRIs were analyzed using 14 fetal brain and skull biometric parameters. We compared measures between DS and controls in both raw MRIs and motion‐corrected and anterior‐posterior commissure‐aligned images.
Results
In the reconstructed images, the measured values of the height of the cerebellar vermis (HV) and anteroposterior diameter of the cerebellar vermis (APDV) were significantly smaller, and the anteroposterior diameter of the fourth ventricle (APDF) was significantly larger in fetuses with DS than controls. In the raw MRIs, the measured values of the right lateral ventricle were significantly larger in fetuses with DS than in controls. Logistic regression analyses revealed that a new parameter, the cerebellar‐to‐fourth‐ventricle ratio (i.e., (APDV * Height of the vermis)/APDF), was significantly smaller in fetuses with DS than controls and was the most predictive to distinguish between fetuses with DS and controls.
Conclusions
The study revealed that fetuses with DS have smaller cerebellums and larger fourth ventricles compared to the controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Obstetrics and Gynecology, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.
- Radiology, Tufts Medical Center, Boston, Massachusetts, USA.
- Department of Neurology, Tufts Medical Center, Boston, Massachusetts, USA.
- Obstetrics and Gynecology, Long Island Jewish Medical Center, New Hyde Park, New York, USA.
- Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Brian G Skotko, Diana W Bianchi, Tomo Tarui
Förderung
- NICHD NIH HHS
- Intramural NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Fondation Jérôme Lejeune
Zitieren
APA
Kitano, R., Madan, N., Mikami, T., Madankumar, R., Skotko, B. G., Santoro, S., Ralston, S. J., Bianchi, D. W., & Tarui, T. (2023). Biometric magnetic resonance imaging analysis of fetal brain development in Down syndrome. Prenatal Diagnosis. https://doi.org/10.1002/pd.6436
Vancouver
Kitano R, Madan N, Mikami T, Madankumar R, Skotko BG, Santoro S, et al. Biometric magnetic resonance imaging analysis of fetal brain development in Down syndrome. Prenatal Diagnosis. 2023. doi:10.1002/pd.6436
BibTeX
@article{Kitano2023,
author = {Kitano, Rie and Madan, Neel and Mikami, Takahisa and Madankumar, Rajeevi and Skotko, Brian G and Santoro, Stephanie and Ralston, Steven J and Bianchi, Diana W and Tarui, Tomo},
title = {Biometric magnetic resonance imaging analysis of fetal brain development in Down syndrome},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6436}
}
EUVIMED